Menu Search
Equities

Euglena Co Ltd

8EG:DEU

Euglena Co Ltd

Actions
  • Price (EUR)3.14
  • Today's Change-0.04 / -1.26%
  • Shares traded0.00
  • 1 Year change-46.32%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.

  • Revenue in JPY (TTM)46.80bn
  • Net income in JPY-2.29bn
  • Incorporated2005
  • Employees846.00
  • Location
    Euglena Co Ltd2F, G-BASE Tamachi, 5-29-11, ShibaMINATO-KU 108-0014JapanJPN
  • Phone+81 334534907
  • Fax+81 354424907
  • Websitehttps://www.euglena.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		2931:TYO since
announced		Transaction
value
Nayuta IncDeal completed10 Jan 202410 Jan 2024Deal completed-23.73%--
Japan Beautech Co LtdDeal completed10 Jan 202410 Jan 2024Deal completed-23.73%10.53m
Saticine Medical Co LtdDeal completed10 Jan 202410 Jan 2024Deal completed-23.73%73.50m
Data delayed at least 20 minutes, as of May 31 2024 07:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.